Apex Metro Secures 11.3% Stake in Cambium Bio
Company Announcements

Apex Metro Secures 11.3% Stake in Cambium Bio

Regeneus Ltd. (AU:CMB) has released an update.

Apex Metro Investments Limited has become a substantial holder in Cambium Bio Limited, acquiring a 11.3% interest through a share swap deal. The transaction involved 69,157,904 ordinary shares, marking a significant move in Cambium Bio’s ownership structure. This strategic acquisition reflects Apex’s commitment to expanding its influence in the biotechnology sector.

For further insights into AU:CMB stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App